LDN specifically targets inflammation and immune modulation, while GLP-1 agonists enhance metabolic control, but also have anti-inflammatory properties
Problem #5: You May Never Be Able to Get Off of Them One of the main reasons that I was able to tolerate the thought of using these medications (even knowing all of these things) is that my intention was always that my patients would eventually be able to get off of them
Appl Clin Genet
doi: 10.3390/jpm11060474 133 ZettergrenA.LordJ.AshtonN
To correlate lux-based bioluminescence and bacterial metabolic activity, stationary-phase JE2 and JE2-lux cultures were subcultured at 1:200 in MHB, incubated at 37 C for 3 h with shaking, then treated with 00.5 mM sodium arsenate (Sigma) for 30 min
The practical protocol: supplement sodium (2,000 to 3,000mg above dietary intake), potassium (1,000 to 2,000mg), and magnesium (300 to 400mg, preferably glycinate or malate form)